| Serial Number | 79062235 |
| Word Mark | KURADURA |
| Filing Date | Friday, August 15, 2008 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, August 15, 2018 |
| Registration Number | 3807132 |
| Registration Date | Tuesday, June 22, 2010 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 6, 2010 |
| Goods and Services | Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement |
| Goods and Services | Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts |
| Pseudo Mark | KUROS DURA |
| Translation of Words in Mark | The wording "KURADURA" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, January 27, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, January 27, 2017 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kuros Biosurgery AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Kuros Biosurgery AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Kuros Biosurgery AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Event Date | Event Description |
| Friday, March 15, 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, March 15, 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| Thursday, January 25, 2018 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, October 27, 2017 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Monday, October 2, 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Monday, October 2, 2017 | INVALIDATION PROCESSED |
| Wednesday, September 27, 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, January 27, 2017 | CANCELLED SECTION 71 |
| Saturday, May 18, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, September 24, 2010 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, September 24, 2010 | FINAL DISPOSITION PROCESSED |
| Wednesday, September 22, 2010 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, June 22, 2010 | REGISTERED-PRINCIPAL REGISTER |
| Friday, June 4, 2010 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, May 20, 2010 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Thursday, May 20, 2010 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, April 6, 2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 6, 2010 | PUBLISHED FOR OPPOSITION |
| Monday, March 1, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, February 25, 2010 | EXPARTE APPEAL TERMINATED |
| Tuesday, February 16, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 16, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 16, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 12, 2010 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, February 12, 2010 | EX PARTE APPEAL-INSTITUTED |
| Friday, February 12, 2010 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Friday, February 12, 2010 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, August 17, 2009 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 17, 2009 | FINAL REFUSAL E-MAILED |
| Monday, August 17, 2009 | FINAL REFUSAL WRITTEN |
| Tuesday, July 21, 2009 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 21, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 21, 2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 21, 2009 | ASSIGNED TO LIE |
| Monday, July 6, 2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 6, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 6, 2009 | REFUSAL PROCESSED BY IB |
| Tuesday, January 6, 2009 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, January 6, 2009 | REFUSAL PROCESSED BY MPU |
| Saturday, January 3, 2009 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 2, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 23, 2008 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 19, 2008 | ASSIGNED TO EXAMINER |
| Friday, December 19, 2008 | NEW APPLICATION ENTERED IN TRAM |
| Thursday, December 18, 2008 | SN ASSIGNED FOR SECT 66A APPL FROM IB |